Sanofi in talks to sell generics arm for $2.4 bln

French healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros ($2.4 billion). Sonia Legg reports.

Save videos for later by signing up or logging in

With "My Queue" you can quickly save videos to watch later.

To add an item to your queue just click the sign next to the video.

Once you've added a video visit "My Queue" to start watching!